TransChromix LLC
Chapel Hill, NC · Biotech · Private
G9a histone methyltransferase inhibitors for Type 1 diabetes immunotherapy
- Grants
- $1.5M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Novel therapeutic intervention of early-stage T1D | $300,670 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel therapeutic intervention of early-stage T1D | $300,670 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel brain-penetrant drugs for translation-targeting therapeutics of Alzheimer’s disease | $497,218 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeting novel translation mechanism to treat NFOO-induced hypoxia-related brain injuries | $399,994 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1433 | Starwise Therapeutics LLC | — | — |
| 1434 | ALLYX THERAPEUTICS INC | — | $40M |
| 1435 | BIOLIFE SOLUTIONS INC | — | $10M |
| 1436 | TransChromix LLC | — | — |
| 1437 | ENTERX BIOSCIENCES, INC. | — | — |
| 1438 | UCB S.A. | — | $788K |
| 1439 | SIWA Biotech Corp. | — | $8.7M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.